Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GADODIAMIDE vs GALCANEZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GADODIAMIDE vs GALCANEZUMAB: Safety Overview

Metric GADODIAMIDE GALCANEZUMAB
Total FAERS Reports 777 379
Deaths Reported 37 2
Death Rate 4.8% 0.5%
Hospitalizations 67 26
Average Patient Age 49.7 yrs 44.6 yrs
% Female Patients 64.6% 88.1%
FDA Approval Date Jan 8, 1993 N/A
Manufacturer GE Healthcare Inc. Eli Lilly and Company
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription N/A